Skip to main content
C

CSPC Innovation Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 300765 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,349 across all filing types
Latest filing 2026-04-27 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300765

About CSPC Innovation Pharmaceutical Co.,Ltd.

https://www.xnwpharma.net

CSPC Innovation Pharmaceutical Co., Ltd. focuses on the research, development, production, and distribution of pharmaceutical products and high-end chemical ingredients. The company is a leading global supplier of caffeine and related derivatives, serving the food, beverage, and pharmaceutical sectors. Its product portfolio includes finished dosage forms such as acarbose for the treatment of type 2 diabetes, as well as various functional health products and nutritional supplements. The organization emphasizes technological innovation and quality control in its manufacturing processes, maintaining large-scale production facilities that adhere to international standards. By leveraging advanced chemical synthesis and biotechnology, the company provides essential ingredients and therapeutic solutions to a diverse international clientele, positioning itself as a key player in the global supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺（杨鹏）
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal nominator’s declaration and commitment regarding the nomination of an independent director candidate. It is filed with the Shenzhen Stock Exchange as part of meeting materials to inform shareholders about the proposed candidate and compliance with regulatory independence requirements. This falls under preparatory materials for shareholder voting, which aligns with Proxy Solicitation & Information Statement (PSI).
2026-04-27 Chinese
上市公司独立董事候选人声明与承诺（邸丛枝）
Regulatory Filings Classification · 1% confidence The document is a formal "Declaration and Commitment" by an independent director candidate for 石药创新制药股份有限公司, listing compliance with regulatory prerequisites and independence requirements. It does not announce an actual board appointment or election results, nor does it contain financial data, proxy vote requests, earnings, ESG information, or any other specialized content. Rather, it is a standalone compliance filing submitted to the Shenzhen Stock Exchange as part of routine regulatory disclosures that do not neatly fit into the other categories. Therefore, it is classified under the fallback category "Regulatory Filings (RNS)".
2026-04-27 Chinese
上市公司独立董事候选人声明与承诺（周宏）
Board/Management Information Classification · 1% confidence The document is a formal declaration and undertaking by an independent director candidate for nomination to the company’s board. It details the candidate’s qualifications, compliance statements, and commitments relating to board independence rules. This is clearly part of a board/management change announcement (nominating an independent director), fitting the “Board/Management Information” category.
2026-04-27 Chinese
战略与ESG委员会工作细则
Governance Information Classification · 1% confidence The document is the detailed internal “Rules of Procedure” (工作细则) for the Board of Directors’ Strategic and ESG Committee, outlining its establishment, composition, responsibilities, meeting rules, and governance processes. This is not an AGM material, financial report, or simple announcement—it is a corporate governance document describing board structure and practices. Therefore, it fits the Governance Information category (CGR).
2026-04-27 Chinese
独立董事提名人声明与承诺（邸丛枝）
Board/Management Information Classification · 1% confidence The document is a public nomination statement and commitment for an independent director candidate by the company’s board. It discloses details around board nomination and compliance with regulatory qualifications. This is a corporate disclosure regarding changes in board composition (an independent director nomination), fitting the “Board/Management Information” category (MANG).
2026-04-27 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 1% confidence The document is a formal announcement by the company regarding the re-election and nomination of the seventh board of directors, detailing candidate names, qualifications, meeting resolutions, and procedural requirements. This clearly falls under announcements of changes in the company's board of directors or senior management.
2026-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.